Semustine
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Semustine is a drug used in chemotherapy.[1] It is structurally similar to lomustine, being distinguished from it only by an additional methyl group. It has been taken off the drug market for investigation of its cancerous effects, rated as IARC Group 1 carcinogen or a known carcinogen.
References
References
- ↑ PMID 1548520 (PMID 1548520)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH